James Carroll has led the Office of National Drug Control Policy in an acting capacity since February. The Senate also confirmed Kelvin Droegemeier to head up the White House’s Office of Science and Technology, giving the office a director for the first time since President Donald Trump's inauguration.
from Kaiser Health News http://bit.ly/2Asq3Jg
January 03, 2019
Rose
Health News, Kaiser Health News
No comments
Senate Confirms ‘Drug Czar’ To Lead Office In Charge Of Administration’s Response To Opioid Epidemic
Related Posts:
Practices With High-Risk Populations Lagging Behind On Medicare’s Annual Wellness VisitsThe initiative was established under the Affordable Care Act to encourage prevention and wellness care for Medicare patients. Meanwhile, the Trump administration has decided not to move forward with an Obama-era program that … Read More
FDA Sharpens Stance Against Herbal Supplement Kratom: ‘It Isn’t Just A Plant — It’s An Opioid’Kratom advocates say the botanical substance is a good way to wean people off of opioids. But new research reinforces Food and Drug Administration's concerns about kratom’s “potential for abuse, addiction and serious health c… Read More
CMS Chief Pledges To Bring A Rural Health Lens To All Agency PoliciesCMS Administrator Seema Verma promises technical help for providers when it comes to implementing new policies like the expansion of telehealth and better "information" to help patients make care decisions. Outlets report on … Read More
How Hospital Nonprofits Structure Themselves Helps Determine How Hard They’re Hit By New Tax RulesUnder the new law, a nonprofit will owe a 21 percent tax on pay exceeding $1 million. But it will owe the tax only on the five highest-paid employees at each tax-exempt entity the nonprofit has registered with the Internal Re… Read More
‘Right To Try’ Legislation Will Do More Harm Than Good, Patient Advocacy Groups Warn CongressMore than three dozen groups say that the FDA's compassionate use program is already in place to help terminal patients access experimental drugs. from Kaiser Health News http://ift.tt/2E6VsF8 … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment